For MST1R expression, statistical differences between PAM50 subsets were only observed in the METABRIC dataset; expression was highest in HER2 breast tumors and lowest in claudin‐low breast tumors (Fig. 5B). This evidence concerns the gene ERBB2 and breast neoplasm.